{"title": "Las c\u00e9lulas inmunes contra el COVID-19 se mantienen altas seis meses despu\u00e9s de la vacunaci\u00f3n", "author": "Europa Press", "url": "https://theobjective.com/sociedad/2021-11-19/celulas-inmunes-covid-6-meses-despues-vacuna/", "hostname": "theobjective.com", "description": "Un estudio realizado por investigadores de Johns Hopkins Medicine, en Estados Unidos, proporciona evidencia de que los linfocitos T CD4+, c\u00e9lulas del", "sitename": "The Objective", "date": "2021-11-19", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Las c\u00e9lulas inmunes contra el COVID-19 se mantienen altas seis meses despu\u00e9s de la vacunaci\u00f3n\nLos investigadores tambi\u00e9n concluyen que las c\u00e9lulas T que estudiaron reconocen y ayudan a proteger contra la variante Delta del SARS-CoV-2\nUn estudio realizado por investigadores de\n[Johns Hopkins Medicine](https://theobjective.com/general/2014-01-13/investigadores-de-la-universidad-de-johns-hopkins-descubren-que-la-cafeina-fortaleza-la-memoria-a4825/), en Estados Unidos, proporciona evidencia de que los linfocitos T CD4+, c\u00e9lulas del sistema inmunol\u00f3gico tambi\u00e9n conocidas como c\u00e9lulas T auxiliares, producidas por personas que recibieron cualquiera de las dos vacunas disponibles de ARN mensajero (ARNm) para [COVID-19](https://theobjective.com/sociedad/2021-11-19/medicamento-covid-reduce-mitad-ema/) persisten seis meses despu\u00e9s de la vacunaci\u00f3n en niveles s\u00f3lo ligeramente reducidos.\nVariante predominante\nEl estudio, publicado en Clinical Infectious Diseases, se\u00f1ala adem\u00e1s que se encuentran en niveles significativamente m\u00e1s altos que para aquellos que no est\u00e1n vacunados. Los investigadores tambi\u00e9n encontraron que las c\u00e9lulas T que estudiaron reconocen y ayudan a proteger contra la\n[variante Delta del SARS-CoV-2](https://theobjective.com/further/sociedad/2021-11-03/dudas-resueltas-variante-delta-plus/), el virus que causa el COVID-19. Esta variante, que es actualmente la predominante en los Estados Unidos, causa m\u00e1s infecciones y se propaga m\u00e1s r\u00e1pido que las formas anteriores del virus.\n\u00abInvestigaciones anteriores han sugerido que la respuesta inmune humoral, donde el sistema inmune hace circular anticuerpos neutralizantes de virus, puede disminuir seis meses despu\u00e9s de la vacunaci\u00f3n, mientras que nuestro estudio indica que la inmunidad celular, donde el sistema inmune ataca directamente a las c\u00e9lulas infectadas, permanece fuerte\u00bb, se\u00f1ala el autor principal del estudio, Joel Blankson, profesor de medicina en la Facultad de Medicina de la Universidad Johns Hopkins.\n\u00abLa persistencia de estas c\u00e9lulas T provocadas por la vacuna, junto con el hecho de que son activas contra la variante delta, tiene implicaciones importantes para guiar el desarrollo de la vacuna COVID y determinar la necesidad de refuerzos COVID en el futuro\u00bb, ha a\u00f1adido.\nPara llegar a estos hallazgos, Blankson y sus colegas obtuvieron sangre de 15 participantes del estudio (10 hombres y cinco mujeres) en tres momentos: antes de la vacunaci\u00f3n, entre siete y 14 d\u00edas despu\u00e9s de su segunda dosis de vacuna Pfizer/BioNTech o Moderna, y seis meses despu\u00e9s de la vacunaci\u00f3n. La mediana de edad de los participantes fue de 41 a\u00f1os y ninguno ten\u00eda evidencia de infecci\u00f3n previa por SARS-CoV-2.\nLos linfocitos T CD4+ reciben su apodo de c\u00e9lulas T auxiliares porque ayudan a otro tipo de c\u00e9lula del sistema inmunol\u00f3gico, el linfocito B (c\u00e9lula B), a responder a las prote\u00ednas de superficie (ant\u00edgenos) en virus como el SARS-CoV-2. Activadas por las c\u00e9lulas T CD4+, las c\u00e9lulas B inmaduras se convierten en c\u00e9lulas plasm\u00e1ticas que producen anticuerpos para marcar las c\u00e9lulas infectadas para su eliminaci\u00f3n del cuerpo o c\u00e9lulas de memoria que \u00abrecuerdan\u00bb la estructura bioqu\u00edmica del ant\u00edgeno para una respuesta m\u00e1s r\u00e1pida a futuras infecciones. Por lo tanto, una respuesta de c\u00e9lulas T CD4+ puede servir como una medida de qu\u00e9 tan bien responde el sistema inmunol\u00f3gico a una vacuna y produce inmunidad humoral.\nEn su estudio, Blankson y sus colegas encontraron que el n\u00famero de c\u00e9lulas T auxiliares que reconocen las prote\u00ednas de pico del SARS-CoV-2 era extremadamente bajo antes de la vacunaci\u00f3n, con una mediana de 2,7 unidades formadoras de manchas (SFU, cuyo nivel es una medida de Frecuencia de c\u00e9lulas T) por mill\u00f3n de c\u00e9lulas mononucleares de sangre perif\u00e9rica (PBMC, identificadas como cualquier c\u00e9lula sangu\u00ednea con un n\u00facleo redondo, incluidos los linfocitos).\nEntre 7 y 14 d\u00edas despu\u00e9s de la vacunaci\u00f3n, la frecuencia de las c\u00e9lulas T aument\u00f3 a una mediana de 237 SFU por mill\u00f3n de PBMC. Seis meses despu\u00e9s de la vacunaci\u00f3n, el nivel se redujo ligeramente a una mediana de 122 SFU por mill\u00f3n de PBMC, una frecuencia de c\u00e9lulas T a\u00fan significativamente m\u00e1s alta que antes de la vacunaci\u00f3n.\nLos investigadores tambi\u00e9n analizaron seis meses despu\u00e9s de la vacunaci\u00f3n la capacidad de las c\u00e9lulas T CD4+ para reconocer prote\u00ednas de pico sobre la variante delta del SARS-CoV-2. Descubrieron que la cantidad de c\u00e9lulas T que reconocen la prote\u00edna de pico variante delta no era significativamente diferente de la de las c\u00e9lulas T sintonizadas con la prote\u00edna de la cepa del virus original.\nUn estudio limitado: se necesita m\u00e1s investigaci\u00f3n\nAunque el estudio fue limitado debido al peque\u00f1o n\u00famero de participantes, Blankson cree que se\u00f1ala \u00e1reas que merecen m\u00e1s investigaci\u00f3n. \u00abLa expansi\u00f3n robusta de las c\u00e9lulas T en respuesta a la estimulaci\u00f3n con prote\u00ednas de pico est\u00e1 ciertamente indicada, lo que respalda la necesidad de m\u00e1s estudios para demostrar que las inyecciones de refuerzo aumentan con \u00e9xito la frecuencia de las c\u00e9lulas T espec\u00edficas del SARS-CoV-2 que circulan en la sangre\u00bb, se\u00f1ala.", "language": null, "image": "https://theobjective.com/wp-content/uploads/2021/11/044653/vacunacion-covid.jpg", "pagetype": "article", "links": ["https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://twitter.com/TheObjective_es", "https://www.instagram.com/theobjective_Es/", "https://www.facebook.com/theobjective.esp", "https://www.youtube.com/c/TheObjective_es", "https://open.spotify.com/user/theobjective_es?si=m4YyKsRFSKaAd11iC1pJrA", "https://es.linkedin.com/company/the-objective-media", "https://medium.com/@TheObjective", "https://www.tiktok.com/@theobjective", "https://theobjective.com/", "https://theobjective.com/espana/", "https://theobjective.com/etiqueta/elecciones-generales/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/castilla-y-leon/", "https://theobjective.com/etiqueta/comunidad-de-madrid/", "https://theobjective.com/etiqueta/comunidad-valenciana/", "https://theobjective.com/etiqueta/pais-vasco/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/cultura/", "https://theobjective.com/etiqueta/literatura/", "https://theobjective.com/etiqueta/musica/", "https://theobjective.com/etiqueta/cine/", "https://theobjective.com/etiqueta/arte/", "https://theobjective.com/etiqueta/series/", "https://theobjective.com/sociedad/", "https://theobjective.com/etiqueta/salud/", "https://theobjective.com/sociedad/medioambiente/", "https://theobjective.com/lifestyle/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/recetas/", "https://theobjective.com/etiqueta/vinos/", "https://theobjective.com/etiqueta/restaurantes/", "https://theobjective.com/gente/", "https://theobjective.com/etiqueta/celebrities/", "https://theobjective.com/etiqueta/casa-real/", "https://theobjective.com/internacional/", "https://theobjective.com/etiqueta/guerra-ucrania-rusia/", "https://theobjective.com/deportes/", "https://theobjective.com/etiqueta/futbol/", "https://theobjective.com/etiqueta/formula-1/", "https://theobjective.com/etiqueta/baloncesto/", "https://theobjective.com/etiqueta/tenis/", "https://theobjective.com/etiqueta/golf/", "https://theobjective.com/motor/", "https://theobjective.com/etiqueta/coches/", "https://theobjective.com/etiqueta/motos/", "https://theobjective.com/etiqueta/movilidad/", "https://theobjective.com/etiqueta/dgt/", "https://theobjective.com/tecnologia/", "https://theobjective.com/tecnologia/videojuegos/", "https://theobjective.com/etiqueta/internet/", "https://theobjective.com/etiqueta/smartphones/", "https://theobjective.com/etiqueta/redes-sociales/", "https://theobjective.com/etiqueta/historia/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/medios/", "https://theobjective.com/medios/television/", "https://theobjective.com/medios/radio/", "https://theobjective.com/etiqueta/programas/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/videos/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/etiqueta/el-purgatorio/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/podcasts/", "https://theobjective.com/etiqueta/al-tanto/", "https://theobjective.com/etiqueta/el-gris-importa/", "https://theobjective.com/etiqueta/sumario-de-tarde/", "https://theobjective.com/galerias/", "https://theobjective.com/productos-recomendados/", "https://informativoscanarias.theobjective.com/", "https://classpaper.theobjective.com/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/principios-y-valores/", "https://theobjective.com/equipo/", "https://theobjective.com/firmas/", "https://theobjective.com/app/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com/sociedad/", "https://theobjective.com/autor/europa-press/", "https://theobjective.com/autor/europa-press/", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-11-19%2Fcelulas-inmunes-covid-6-meses-despues-vacuna%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-11-19%2Fcelulas-inmunes-covid-6-meses-despues-vacuna%2F&text=Las%20c%C3%A9lulas%20inmunes%20contra%20el%20COVID-19%20se%20mantienen%20altas%20seis%20meses%20despu%C3%A9s%20de%20la%20vacunaci%C3%B3n&via=TheObjective_es", "//web.whatsapp.com/send?text=Las%20c%C3%A9lulas%20inmunes%20contra%20el%20COVID-19%20se%20mantienen%20altas%20seis%20meses%20despu%C3%A9s%20de%20la%20vacunaci%C3%B3n | The Objective%20https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-11-19%2Fcelulas-inmunes-covid-6-meses-despues-vacuna%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-11-19%2Fcelulas-inmunes-covid-6-meses-despues-vacuna%2F&title=Las%20c%C3%A9lulas%20inmunes%20contra%20el%20COVID-19%20se%20mantienen%20altas%20seis%20meses%20despu%C3%A9s%20de%20la%20vacunaci%C3%B3n", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-11-19%2Fcelulas-inmunes-covid-6-meses-despues-vacuna%2F&text=Las%20c%C3%A9lulas%20inmunes%20contra%20el%20COVID-19%20se%20mantienen%20altas%20seis%20meses%20despu%C3%A9s%20de%20la%20vacunaci%C3%B3n%20The Objective", "/cdn-cgi/l/email-protection#dde2aea8bfb7b8bea9e089b8f8efedada8b8b9b8f8efedb4b3a9b8afb8aebcaff3f3f3fbbfb2b9a4e091bcaef8efedbef89eeef89ce4b1a8b1bcaef8efedb4b3b0a8b3b8aef8efedbeb2b3a9afbcf8efedb8b1f8efed9e928b9499f0ece4f8efedaeb8f8efedb0bcb3a9b4b8b3b8b3f8efedbcb1a9bcaef8efedaeb8b4aef8efedb0b8aeb8aef8efedb9b8aeada8f89eeef89ce4aef8efedb9b8f8efedb1bcf8efedabbcbea8b3bcbeb4f89eeef89feeb3f8efedb5a9a9adaef8ee9cf8ef9bf8ef9ba9b5b8b2bfb7b8bea9b4abb8f3beb2b0f8ef9baeb2beb4b8b9bcb9f8ef9befedefecf0ececf0ece4f8ef9bbeb8b1a8b1bcaef0b4b3b0a8b3b8aef0beb2abb4b9f0ebf0b0b8aeb8aef0b9b8aeada8b8aef0abbcbea8b3bcf8ef9b", "https://theobjective.com/general/2014-01-13/investigadores-de-la-universidad-de-johns-hopkins-descubren-que-la-cafeina-fortaleza-la-memoria-a4825/", "https://theobjective.com/sociedad/2021-11-19/medicamento-covid-reduce-mitad-ema/", "https://theobjective.com/further/sociedad/2021-11-03/dudas-resueltas-variante-delta-plus/", "https://theobjective.com/autor/europa-press/", "https://theobjective.com/autor/europa-press/", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-11-19%2Fcelulas-inmunes-covid-6-meses-despues-vacuna%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-11-19%2Fcelulas-inmunes-covid-6-meses-despues-vacuna%2F&text=Las%20c%C3%A9lulas%20inmunes%20contra%20el%20COVID-19%20se%20mantienen%20altas%20seis%20meses%20despu%C3%A9s%20de%20la%20vacunaci%C3%B3n&via=TheObjective_es", "//web.whatsapp.com/send?text=Las%20c%C3%A9lulas%20inmunes%20contra%20el%20COVID-19%20se%20mantienen%20altas%20seis%20meses%20despu%C3%A9s%20de%20la%20vacunaci%C3%B3n | The Objective%20https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-11-19%2Fcelulas-inmunes-covid-6-meses-despues-vacuna%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-11-19%2Fcelulas-inmunes-covid-6-meses-despues-vacuna%2F&title=Las%20c%C3%A9lulas%20inmunes%20contra%20el%20COVID-19%20se%20mantienen%20altas%20seis%20meses%20despu%C3%A9s%20de%20la%20vacunaci%C3%B3n", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-11-19%2Fcelulas-inmunes-covid-6-meses-despues-vacuna%2F&text=Las%20c%C3%A9lulas%20inmunes%20contra%20el%20COVID-19%20se%20mantienen%20altas%20seis%20meses%20despu%C3%A9s%20de%20la%20vacunaci%C3%B3n%20The Objective", "/cdn-cgi/l/email-protection#9ea1edebfcf4fbfdeaa3cafbbbacaeeeebfbfafbbbacaef7f0eafbecfbedffecb0b0b0b8fcf1fae7a3d2ffedbbacaefdbbddadbbdfa7f2ebf2ffedbbacaef7f0f3ebf0fbedbbacaefdf1f0eaecffbbacaefbf2bbacaeddd1c8d7dab3afa7bbacaeedfbbbacaef3fff0eaf7fbf0fbf0bbacaefff2eaffedbbacaeedfbf7edbbacaef3fbedfbedbbacaefafbedeeebbbddadbbdfa7edbbacaefafbbbacaef2ffbbacaee8fffdebf0fffdf7bbddadbbdcadf0bbacaef6eaeaeeedbbaddfbbacd8bbacd8eaf6fbf1fcf4fbfdeaf7e8fbb0fdf1f3bbacd8edf1fdf7fbfafffabbacd8acaeacafb3afafb3afa7bbacd8fdfbf2ebf2ffedb3f7f0f3ebf0fbedb3fdf1e8f7fab3a8b3f3fbedfbedb3fafbedeeebfbedb3e8fffdebf0ffbbacd8", "https://news.google.com/publications/CAAiELumQ8m_nwDuO-xzhLPkxhgqFAgKIhC7pkPJv58A7jvsc4Sz5MYY?ceid=ES:es&oc=3", "https://theobjective.com/etiqueta/ciencia/", "https://theobjective.com/etiqueta/coronavirus/", "https://theobjective.com/etiqueta/salud/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/sociedad/2021-11-26/mujer-belgica-primer-caso-confirmado-nueva-variante-nu/", "https://theobjective.com/sociedad/2021-11-26/mujer-belgica-primer-caso-confirmado-nueva-variante-nu/", "https://theobjective.com/sociedad/2021-11-26/investigadores-espanoles-metastasis-melanoma/", "https://theobjective.com/sociedad/2021-11-26/investigadores-espanoles-metastasis-melanoma/", "https://theobjective.com/sociedad/2021-11-26/oms-omicron-variante/", "https://theobjective.com/sociedad/2021-11-26/oms-omicron-variante/", "https://theobjective.com/sociedad/2021-11-26/antivirales-coronavirus/", "https://theobjective.com/sociedad/2021-11-26/antivirales-coronavirus/", "https://theobjective.com/sociedad/2021-11-26/covid-espana-datos/", "https://theobjective.com/sociedad/2021-11-26/pasaporte-covid-cataluna-colapsa/", "https://theobjective.com/sociedad/2021-11-25/vacuna-covid-salva-medio-millon-vidas-europa/", "https://theobjective.com/sociedad/2021-11-25/sanidad-datos-covid__trashed/", "https://theobjective.com/espana/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/etiqueta/madrid/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/sociedad/", "https://theobjective.com/cultura/", "https://theobjective.com/deportes/", "https://theobjective.com/internacional/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/lifestyle/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gente/", "https://theobjective.com/videos/", "https://theobjective.com/podcasts/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/branded-content/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/etiqueta/contraluz/", "https://theobjective.com/etiqueta/la-mirilla/", "https://theobjective.com/etiqueta/el-buzon-secreto/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/newsletters/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/politica-de-privacidad/", "https://theobjective.com/politica-de-cookies/", "https://theobjective.com/aviso-legal/", "https://theobjective.com/contactanos/", "https://theobjective.com/newsletters", "https://theobjective.com/terminos-y-condiciones", "https://theobjective.com/politica-de-privacidad", "https://theobjective.com"]}